Stocking up on biotech stocks is going to mean a big year for deals.  Who can benefit.

Stocking up on biotech stocks is going to mean a big year for deals. Who can benefit.

Nearly two years after biotech stocks began to crash, small- and mid-cap executives in the space finally accept that stock prices aren’t going down anytime soon. As reality sets in, it’s become a buyer’s market for companies looking for acquisitions and partnerships, according to several pharma and medical technology executives gathered this year. JPMorgan Healthcare …

Stocking up on biotech stocks is going to mean a big year for deals. Who can benefit. Read More »